Daiichi Sankyo Company, Limited 4568.T Open Daiichi Sankyo Company, Limited in new tab
Daiichi Sankyo Company, Limited Analysis (4568.T)
Is Daiichi Sankyo Company, Limited a good investment? Daiichi Sankyo Company, Limited (4568.T) is currently trading at 5337.00 JPY. Market analysts have a consensus price target of 5988.50 JPY. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 55.33. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Daiichi Sankyo Company, Limited is expected to release its next earnings report on April 27, 2026. The market consensus estimate for Forward EPS is 132.55.
For income investors, Daiichi Sankyo Company, Limited pays a dividend yield of 1.13%. With a payout ratio of 48%, the dividend appears sustainable.
Investor FAQ
Does Daiichi Sankyo Company, Limited pay a dividend?
Yes, it pays an annual dividend of 60.00 JPY (1.13% yield).
What asset class is Daiichi Sankyo Company, Limited?
Daiichi Sankyo Company, Limited is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be April 27, 2026. The company currently has a trailing EPS of 104.34.
Company Profile
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia. It also provides olmesartan medoxomil antihypertensive agents; NILEMDO, an oral treatment to help in lowering cholesterol; and Nustendi, a fixed-dose combination tablet of bempedoic acid and ezetimibe for reducing cholesterol. In addition, the company offers Canalia for the treatment of type 2 diabetes mellitus; Emgalty for the treatment of migraine attacks; Pralia for the treatment of anti-osteoporosis/inhibitor of the progression of bone erosion associated with rheumatoid arthritis; Ranmark for the treatment of bone complications caused by bone metastasis from tumors; Tarlige for treating pain; Tenelia for the treatment of Type 2 diabetes mellitus; Venofer for the treatment of iron deficiency anemia; and Vimpat, an anti-epileptic agent. Further, it provides vaccines for influenza, measles/rubella infection, and mumps. The company has a development and commercialization agreement with Merck to jointly develop and commercialize Daiichi Sankyo's DXd antibody drug conjugate (ADC) candidates The company was founded in 1899 and is headquartered in Tokyo, Japan.
Dividend Yield
1.13% (5y avg: 1.05%)
Annual Dividends
60.00 JPY
Next ex. div date
March 30, 2027
Payout Ratio
47.79%
Historical Dividends
| Year | Total Dividends |
|---|---|
| 2027 | 50.00 JPY |
| March 30, 2027 | 50.0000 |
| 2026 | 39.00 JPY |
| June 24, 2026 | 39.0000 |
| 2025 | 69.00 JPY |
| Dec. 10, 2025 | 39.0000 |
| June 24, 2025 | 30.0000 |
| 2024 | 60.00 JPY |
| Dec. 10, 2024 | 30.0000 |
| June 18, 2024 | 30.0000 |
| 2023 | 35.00 JPY |
| Dec. 8, 2023 | 20.0000 |
| June 20, 2023 | 15.0000 |
| 2022 | 27.00 JPY |
| Dec. 1, 2022 | 13.5000 |
| June 28, 2022 | 13.5000 |
| 2021 | 27.00 JPY |
| Dec. 1, 2021 | 13.5000 |
| June 22, 2021 | 13.5000 |
| 2020 | 48.50 JPY |
| Dec. 1, 2020 | 13.5000 |
| June 16, 2020 | 35.0000 |
| 2019 | 70.00 JPY |
| Dec. 2, 2019 | 35.0000 |
| June 18, 2019 | 35.0000 |
| 2018 | 70.00 JPY |
| Dec. 3, 2018 | 35.0000 |
| June 19, 2018 | 35.0000 |
| 2017 | 70.00 JPY |
| Dec. 1, 2017 | 35.0000 |
| June 20, 2017 | 35.0000 |
| 2016 | 65.00 JPY |
| Sept. 28, 2016 | 35.0000 |
| March 29, 2016 | 30.0000 |
| 2015 | 40.00 JPY |
| Sept. 28, 2015 | 10.0000 |
| March 27, 2015 | 30.0000 |
| 2014 | 60.00 JPY |
| Sept. 26, 2014 | 30.0000 |
| March 27, 2014 | 30.0000 |
| 2013 | 60.00 JPY |
| Sept. 26, 2013 | 30.0000 |
| March 27, 2013 | 30.0000 |
| 2012 | 60.00 JPY |
| Sept. 26, 2012 | 30.0000 |
| March 28, 2012 | 30.0000 |
| 2011 | 60.00 JPY |
| Sept. 28, 2011 | 30.0000 |
| March 29, 2011 | 30.0000 |
| 2010 | 60.00 JPY |
| Sept. 28, 2010 | 30.0000 |
| March 29, 2010 | 30.0000 |
| 2009 | 70.00 JPY |
| Sept. 25, 2009 | 30.0000 |
| March 26, 2009 | 40.0000 |
| 2008 | 75.00 JPY |
| Sept. 25, 2008 | 40.0000 |
| March 26, 2008 | 35.0000 |
| 2007 | 65.00 JPY |
| Sept. 25, 2007 | 35.0000 |
| March 27, 2007 | 30.0000 |
| 2006 | 55.00 JPY |
| Sept. 26, 2006 | 30.0000 |
| March 28, 2006 | 25.0000 |
| 2005 | 75.00 JPY |
| March 28, 2005 | 75.0000 |
| 2004 | 22.50 JPY |
| Sept. 27, 2004 | 15.0000 |
| March 26, 2004 | 7.5000 |
| 2003 | 20.00 JPY |
| Sept. 25, 2003 | 10.0000 |
| March 26, 2003 | 10.0000 |
| 2002 | 15.00 JPY |
| Sept. 25, 2002 | 12.5000 |
| March 26, 2002 | 2.5000 |
| 2001 | 14.75 JPY |
| Sept. 25, 2001 | 2.5000 |
| March 27, 2001 | 12.2500 |
| 2000 | 24.50 JPY |
| Sept. 26, 2000 | 12.2500 |
| March 28, 2000 | 12.2500 |
Yearly aggregated dividends
Dividends
|
Daiichi Sankyo Company, Limited
Mar 30, 2027 Upcoming
Dividend
50.0 JPY |
|
Daiichi Sankyo Company, Limited
Jun 24, 2026 Upcoming
Dividend
39.0 JPY |
|
Daiichi Sankyo Company, Limited
Dec 10, 2025 Paid
Dividend
39.0 JPY |
Historical Split Corporate Actions
| Split Date | Split Ratio to 1 |
|---|---|
| Sept. 29, 2020 | 3.000000 |
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion